Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418919
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-10
Brief Title:
A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves Disease
Sponsor:
The University of Hong Kong
Organization:
The University of Hong Kong
Study Overview
Official Title:
A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves Disease
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There have been previous reports of using High-intensity focused ultrasound HIFU as a feasible thermal ablative treatment for relapsed Graves disease In recent years radiofrequency ablation RFA has become another promising alternative for thermal ablation of benign thyroid nodules RFA has the advantage of avoiding a surgical scar organ preservation and being an ambulatory procedure It utilizes a small caliber radiofrequency electrode which is inserted into the thyroid gland percutaneously The active tip of the RF electrode would induce frictional heat in the surrounding tissue causing a thermal ablative effect The direct application of energy of RFA to tissue is different from that in HIFU in which energy is transmitted through the skin of the participants from the transducer
Studies of follow-up after RFA of Graves disease have not been published Given the previous successful experience with HIFU the investigators would like to explore the feasibility safety and efficacy of RFA as an alternative thermal ablation option for relapsed Graves disease Thus the purpose of this prospective study is to assess the efficacy and safety of US-guided RFA for the treatment of relapsed Graves disease
Studies of follow-up after RFA of Graves disease have not been published Given the previous successful experience with HIFU the investigators would like to explore the feasibility safety and efficacy of RFA as an alternative thermal ablation option for relapsed Graves disease Thus the purpose of this prospective study is to assess the efficacy and safety of US-guided RFA for the treatment of relapsed Graves disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None